Bicyclo-pyrazoles of formula (I) as defined in the specification, and
pharmaceutically acceptable salts thereof, process for their preparation
and pharmaceutical compositions comprising them are disclosed; the
compounds of the invention may be useful, in therapy, in the treatment of
diseases associated with a disregulated protein kinase activity, like
cancer.